Record-Breaking Price Performance
On 19 May 2026, Integrated Proteins Ltd’s stock price surged to Rs.127, setting a new 52-week and all-time high. This peak represents a substantial appreciation from its 52-week low of Rs.20.71, marking a staggering 513.23% increase from the lowest point in the past year. The stock has outperformed its sector and broader market indices consistently, with a year-to-date return of 269.19% compared to the Sensex’s decline of 11.20% over the same period.
The stock’s momentum is further highlighted by its 12 consecutive days of gains, during which it delivered a cumulative return of 21.94%. Today’s performance also outpaced the edible oil sector, with Integrated Proteins Ltd outperforming by 4.01% while the solvent extraction segment declined by 3.61%.
Technical Strength and Market Positioning
Integrated Proteins Ltd is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a robust bullish trend. The overall technical outlook remains positive, with multiple indicators such as MACD, Bollinger Bands, and Dow Theory confirming a bullish stance on both weekly and monthly timeframes. The stock’s immediate support level is anchored at Rs.20.71, its 52-week low, while the recent resistance levels at Rs.108.48 and Rs.57.82 have been decisively surpassed.
Delivery volumes have shown a marked increase, with a 1-day delivery change of 155.41% compared to the 5-day average and a 1-month delivery volume growth of 91.37%, indicating strong investor participation in recent trading sessions.
Long-Term Performance Metrics
Integrated Proteins Ltd’s long-term performance is exceptional, with a three-year return of 1,051.41% and a ten-year return of 5,834.58%, vastly outperforming the Sensex’s respective returns of 22.59% and 197.93%. This extraordinary growth trajectory highlights the company’s sustained value creation over the past decade.
Shorter-term returns also reflect this strength, with the stock delivering 41.38% over the past month and 310.34% over the past three months, while the Sensex recorded negative returns in these periods. The stock’s resilience and upward trajectory have been consistent despite broader market volatility.
Valuation and Financial Metrics
At the current price of Rs.127, Integrated Proteins Ltd trades at a price-to-earnings (P/E) ratio of 719x, reflecting elevated market expectations relative to trailing earnings. The price-to-book value stands at 11.66x, and the enterprise value to EBITDA ratio is 237.38x, indicating a premium valuation consistent with the stock’s strong price appreciation.
Dividend metrics are not applicable as the company has not declared dividends recently, and the dividend yield remains unavailable. The valuation assessment data is not available, but the premium multiples suggest the market is pricing in the company’s growth and sector leadership.
Quality and Financial Health
Integrated Proteins Ltd’s quality assessment categorises it as a below-average quality company based on long-term financial performance. Key factors include below-average management risk and capital structure, with average growth metrics. The company has demonstrated a 5-year sales growth CAGR of 92.87%, indicating strong top-line expansion, although EBIT growth over the same period is modest at 7.26%.
Financial leverage remains low, with negligible debt levels and no promoter share pledging, supporting a strong balance sheet. However, profitability ratios such as average ROCE and ROE are weak, at -5.14% and 1.51% respectively, reflecting challenges in converting sales growth into consistent returns.
Recent Financial Trends
The short-term financial trend as of December 2025 is flat, with quarterly earnings per share (EPS) at a low of ₹-0.06. Despite this, the stock’s price appreciation and technical strength suggest market confidence in the company’s underlying business prospects and sector positioning.
Sector and Market Context
Integrated Proteins Ltd operates within the edible oil industry, a sector that has experienced mixed performance recently. While the solvent extraction segment has declined by 3.61%, Integrated Proteins Ltd has bucked the trend with strong gains and sustained bullish momentum. The stock’s micro-cap status places it among smaller companies in the sector, yet its market capitalisation and price performance have attracted notable attention.
Today’s marginal day change of 0.12% contrasts with the Sensex’s 0.48% gain, reflecting the stock’s relative stability amid broader market fluctuations.
Conclusion
Integrated Proteins Ltd’s achievement of an all-time high price of Rs.127 on 19 May 2026 marks a significant milestone in its market journey. The stock’s exceptional returns over multiple time horizons, combined with a strong technical profile and increased delivery volumes, underscore its prominent position within the edible oil sector. While valuation multiples remain elevated and quality metrics indicate areas for improvement, the company’s sustained price momentum and long-term growth record highlight its noteworthy performance in a competitive industry landscape.
